The chemicals that can modulate RAMP3 activity are primarily involved in GPCR signaling pathways. These compounds do not directly activate RAMP3 but affect the signaling pathways in which RAMP3 plays a modulatory role. This approach is due to RAMP3's function as a regulator of GPCR activity rather than a direct target for chemical activation. Compounds like CGRP, Adrenomedullin, and Amylin interact with CLR, a receptor that forms complexes with RAMP3. The interaction of these ligands with CLR-RAMP3 complexes can modulate the signaling pathways, thereby indirectly influencing RAMP3's role. This modulation is crucial for understanding the diverse physiological functions of RAMP3, as it alters receptor pharmacology and trafficking.
Other chemicals in this list, such as Forskolin, Isoproterenol, Pindolol, and Propranolol, influence the broader spectrum of GPCR signaling. By modulating adenylate cyclase activity or beta-adrenergic receptor signaling, these compounds indirectly affect the signaling landscape in which RAMP3 operates. This includes influencing levels of cAMP, a key second messenger in GPCR signaling. Inhibitors like Pertussis Toxin and Cholera Toxin target specific G-protein subunits, thereby altering GPCR signaling dynamics. NF449 and YM-254890 are more specific in their action on G-protein subunits, offering insights into how different G-protein pathways might interact with RAMP3-modulated receptors. U73122, by inhibiting phospholipase C, provides another avenue to influence GPCR signaling pathways, thereby modulating RAMP3 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, influencing cAMP levels, which can modulate GPCR signaling pathways involving RAMP3. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A beta-adrenergic agonist that can influence GPCR signaling pathways, potentially impacting RAMP3 functionality. | ||||||
Pindolol | 13523-86-9 | sc-204847 sc-204847A | 100 mg 1 g | $194.00 $760.00 | ||
A beta-adrenergic antagonist, which by modulating GPCR activity, could indirectly influence RAMP3-associated pathways. | ||||||
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
Another beta-adrenergic antagonist that can affect GPCR signaling pathways, potentially impacting RAMP3. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $203.00 $469.00 $1509.00 | 1 | |
A Gs alpha subunit-specific antagonist that might impact signaling pathways involving RAMP3. | ||||||
YM 254890 | 568580-02-9 | sc-507356 | 1 mg | $510.00 | ||
Selectively inhibits Gq/11 proteins, potentially affecting GPCR signaling pathways in which RAMP3 is involved. | ||||||